Skip to main content

Table 1 Baseline characteristics of all study participants

From: Change of renal function after short-term use of cardioprotective agents in patients with type 2 diabetes is not accurately assessed by the change of estimated glomerular filtration rate: an observational study

  All participants (n = 190)
Age (years) 59 ± 9
Sex (n, %) Male: 135 (71%)
Female: 55 (29%)
BMI (kg/m2) 30.1 ± 4.6
Body surface area (m2) 2.1 ± 0.2
Systolic blood pressure (mmHg) 137 ± 14
Diastolic blood pressure (mmHg) 81 ± 9
FP-glucose (mg/dl) 158 ± 46
HbA1c (%) 7.1 ± 0.9
Serum creatinine (mg/dl) 0.81 ± 0.15
mGFR indexed to BSA (ml/min/1.73m2) 111 ± 20
eGFR by CKD-EPI (ml/min/1.73m2) 93 ± 13
UACR (mg/g creatinine) 10.3 (6.8–21.2)
Microalbuminuria (n, %) 21 (11%)
Diabetes duration (years) 5.4 (2.6–8.6)
  1. Data are mean ± SD or median (interquartile range, IQR). BMI, body mass index; FP-glucose, fasting-plasma glucose; HbA1c, glycated haemoglobin; mGFR, measured glomerular filtration rate; BSA, body surface area; eGFR, estimated glomerular filtration rate; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; UACR, urine albumin to creatinine ratio